SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Artificial Intelligence

PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 2127908

Cover Image

PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 2127908

AI in Pharma Manufacturing Market Size, Share, Growth and Global Industry Analysis, Regional Insights and Forecast to 2026-2034

PUBLISHED:
PAGES: 224 Pages
DELIVERY TIME: 2-3 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4850
Unprintable PDF & Excel (Multi User License)
USD 5850
PDF, Excel & PPT (Enterprise License)
USD 6850

Add to Cart

Description

Table of Contents

List of Tables

Growth Factors of AI in pharma manufacturing Market

The global AI in pharma manufacturing market was valued at USD 1.26 billion in 2025 and is projected to grow from USD 1.64 billion in 2026 to USD 12.90 billion by 2034, registering a CAGR of 29.45% during the forecast period. North America dominated the global market in 2025, accounting for 38.88% of the overall market share.

Artificial intelligence is rapidly transforming pharmaceutical manufacturing by improving production efficiency, ensuring regulatory compliance, enhancing quality control, and reducing operational costs. AI-powered platforms are increasingly integrated across manufacturing processes, including research and technology transfer, upstream and downstream production, fill-finish operations, packaging, predictive maintenance, quality assurance, and supply chain management. Growing production of biologics, vaccines, cell and gene therapies, and complex small-molecule drugs is accelerating the adoption of AI-driven manufacturing technologies worldwide.

Market Trends

One of the most significant trends shaping the AI in pharma manufacturing market is the increasing adoption of AI-powered quality control and compliance automation. Pharmaceutical manufacturers are leveraging machine learning, computer vision, and advanced analytics to monitor production processes in real time, detect deviations, automate documentation, and improve batch review procedures. AI-enabled inspection systems also reduce manual errors, improve product consistency, and accelerate product release while ensuring compliance with Good Manufacturing Practices (GMP). The growing implementation of cloud-based manufacturing execution systems (MES), digital twins, and predictive analytics is further supporting digital transformation across pharmaceutical manufacturing facilities.

Market Drivers

The growing demand for advanced digital manufacturing infrastructure is a major driver supporting market expansion. Pharmaceutical companies are replacing traditional paper-based manufacturing systems with AI-enabled digital platforms that provide real-time production monitoring, automated workflows, and predictive process optimization. AI helps manufacturers reduce downtime, improve production yields, accelerate technology transfer, and shorten product development timelines. The rapid adoption of Pharma 4.0 initiatives and increasing investments in smart manufacturing facilities continue to strengthen market growth.

Market Restraints

Despite significant growth opportunities, the market faces challenges due to the high implementation and integration costs associated with AI technologies. Deploying AI solutions often requires upgrading manufacturing execution systems, integrating equipment, establishing cloud infrastructure, ensuring cybersecurity, validating AI models, and training employees. These investments can be substantial, particularly for small and mid-sized pharmaceutical manufacturers and contract manufacturing organizations, limiting widespread adoption.

Market Opportunities

Growing adoption of AI-powered quality inspection and assurance presents a major opportunity for industry participants. Computer vision systems can accurately identify defects in pharmaceutical products, including vials, syringes, tablets, labels, and packaging materials. AI also supports predictive quality analytics, automated batch review, and continuous process monitoring, enabling manufacturers to reduce product recalls, minimize waste, improve compliance, and achieve faster product release. Increasing investments in digital manufacturing platforms are expected to create new growth opportunities throughout the forecast period.

Market Challenges

A key challenge for the industry is the complexity of regulatory compliance and AI validation. Pharmaceutical companies must demonstrate that AI systems remain accurate, transparent, traceable, and compliant throughout their lifecycle. Regulatory uncertainty regarding AI model validation, audit trails, data integrity, and continuous model monitoring increases implementation complexity and slows adoption in critical manufacturing operations.

Segmentation Analysis

Based on component, the software/platforms segment dominated the market in 2025 due to rising demand for cloud-based manufacturing execution systems, automated workflows, and real-time production visibility. The services segment is expected to witness significant growth as implementation and consulting requirements increase.

By deployment, the cloud-based segment held the largest market share owing to faster deployment, scalability, remote monitoring capabilities, and lower infrastructure costs. Hybrid deployment models are also gaining traction among highly regulated pharmaceutical manufacturers.

Based on technology, the others segment, including digital twins, industrial IoT, robotics, and generative AI, accounted for the largest share. Meanwhile, computer vision is projected to record the fastest growth due to increasing use in automated visual inspection and quality assurance.

By manufacturing stage, quality control and quality assurance dominated the market as pharmaceutical companies increasingly rely on AI for inspection, anomaly detection, predictive quality management, and regulatory compliance.

Based on application, process optimization and control held the largest market share in 2025, driven by growing demand for improved production efficiency, reduced batch failures, and enhanced process consistency.

Among products, small molecule drugs accounted for the largest share owing to their high production volumes and extensive adoption of AI for manufacturing optimization. By end user, pharmaceutical companies remained the leading segment due to substantial investments in digital manufacturing and enterprise-wide AI implementation.

Regional Outlook

North America dominated the global AI in pharma manufacturing market in 2025 with a market size of USD 0.49 billion. The region benefits from advanced pharmaceutical manufacturing infrastructure, early adoption of AI technologies, strong regulatory frameworks, and the presence of leading pharmaceutical companies. The U.S. market is projected to reach approximately USD 0.57 billion in 2026.

Europe continues to witness steady growth due to widespread adoption of Pharma 4.0 initiatives, strict GMP compliance standards, and increasing investments in digital manufacturing. Germany and the U.K. remain major contributors to regional expansion.

Asia Pacific is expected to experience the fastest growth during the forecast period, supported by expanding pharmaceutical manufacturing capacity across China, India, Japan, South Korea, and Singapore. Rising investments in biologics, APIs, vaccines, and CDMO facilities are driving AI adoption throughout the region.

Latin America and the Middle East & Africa are gradually expanding their presence through increased investments in pharmaceutical manufacturing infrastructure, supply chain modernization, and vaccine production capabilities.

Competitive Landscape

The AI in pharma manufacturing market remains moderately competitive, with leading companies focusing on product innovation, cloud-based manufacturing platforms, automation, AI-powered analytics, and strategic partnerships. Major industry participants include Siemens AG, Rockwell Automation, Honeywell International, Emerson Electric, Schneider Electric, ABB, Korber AG, Dassault Systemes, Danaher Corporation (Cytiva), and MasterControl Solutions. Companies continue investing in AI-enabled manufacturing execution systems, digital twins, predictive maintenance solutions, and quality management platforms to strengthen their competitive position.

Conclusion

The AI in pharma manufacturing market is poised for exceptional growth as pharmaceutical companies accelerate digital transformation to improve production efficiency, product quality, regulatory compliance, and operational flexibility. Rising adoption of AI-driven quality control, predictive maintenance, cloud-based manufacturing platforms, and Pharma 4.0 technologies will continue to drive market expansion. With the market increasing from USD 1.26 billion in 2025 to USD 1.64 billion in 2026, and projected to reach USD 12.90 billion by 2034, AI is expected to become a core technology enabling the future of intelligent pharmaceutical manufacturing.

Segmentation By Component, Deployment, Technology, Manufacturing Stage, Application, Product, End User, and Region

By Component * Software/Platforms

  • Services

By Deployment * Cloud-Based

  • On-Premise
  • Hybrid

By Technology * Computer Vision

  • Machine Learning & Deep Learning
  • Others

By Manufacturing Stage * R&D/Tech Transfer

  • Upstream Processing
  • Downstream Processing
  • Fill-Finish & Packaging
  • Quality Control/QA
  • Others

By Application * Production Planning & Scheduling

  • Process Optimization & Control
  • Quality Inspection & Assurance
  • Predictive Maintenance
  • Batch Record Review & Compliance
  • Supply Chain & Inventory Optimization
  • Others

By Product * Small Molecule Drugs

  • Biologics
  • Vaccines
  • Cell & Gene Therapies
  • Others

By End User * Pharmaceutical Companies

  • Biotechnology Companies
  • CDMOs/CMOs
  • Cell & Gene Therapy Manufacturers
  • Others

By Region * North America (By Component, Deployment, Technology, Manufacturing Stage, Application, Product, End User, and Country)

    • U.S.
    • Canada
  • Europe (By Component, Deployment, Technology, Manufacturing Stage, Application, Product, End User, and Country/Sub-region)
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Component, Deployment, Technology, Manufacturing Stage, Application, Product, End User, and Country/Sub-region)
    • China
    • Japan
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Component, Deployment, Technology, Manufacturing Stage, Application, Product, End User, and Country/Sub-region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Component, Deployment, Technology, Manufacturing Stage, Application, Product, End User, and Country/Sub-region)
    • GCC
    • South Africa
    • Rest of Middle East & Africa
Show more
Product Code: FBI117654

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends
  • 3.5. Market Challenges

4. Key Insights

  • 4.1. Technological Advancements in AI in Pharma Manufacturing
  • 4.2. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
  • 4.3. New Product Launches, By Key Players
  • 4.4. Key Strat-ups in this market

5. Global AI in Pharma Manufacturing Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Component
    • 5.1.1. Software/Platforms
    • 5.1.2. Services
  • 5.2. Market Analysis, Insights and Forecast - By Deployment
    • 5.2.1. Cloud-Based
    • 5.2.2. On-Premise
    • 5.2.3. Hybrid
  • 5.3. Market Analysis, Insights and Forecast - By Technology
    • 5.3.1. Machine Learning & Deep Learning
    • 5.3.2. Computer Vision
    • 5.3.3. Others
  • 5.4. Market Analysis, Insights and Forecast - By Manufacturing Stage
    • 5.4.1. R&D/Tech Transfer
    • 5.4.2. Upstream Processing
    • 5.4.3. Downstream Processing
    • 5.4.4. Fill-Finish & Packaging
    • 5.4.5. Quality Control/QA
    • 5.4.6. Others
  • 5.5. Market Analysis, Insights and Forecast - By Application
    • 5.5.1. Production Planning & Scheduling
    • 5.5.2. Process Optimization & Control
    • 5.5.3. Quality Inspection & Assurance
    • 5.5.4. Predictive Maintenance
    • 5.5.5. Batch Record Review & Compliance
    • 5.5.6. Supply Chain & Inventory Optimization
    • 5.5.7. Others
  • 5.6. Market Analysis, Insights and Forecast - By Product
    • 5.6.1. Small Molecule Drugs
    • 5.6.2. Biologics
    • 5.6.3. Vaccines
    • 5.6.4. Cell & Gene Therapies
    • 5.6.5. Others
  • 5.7. Market Analysis, Insights and Forecast - By End User
    • 5.7.1. Pharmaceutical Companies
    • 5.7.2. Biotechnology Companies
    • 5.7.3. CDMOs/CMOs
    • 5.7.4. Cell & Gene Therapy Manufacturers
    • 5.7.5. Others
  • 5.8. Market Analysis, Insights and Forecast - Region
    • 5.8.1. North America
    • 5.8.2. Europe
    • 5.8.3. Asia Pacific
    • 5.8.4. Latin America
    • 5.8.5. Middle East & Africa

6. North America AI in Pharma Manufacturing Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Component
    • 6.1.1. Software/Platforms
    • 6.1.2. Services
  • 6.2. Market Analysis, Insights and Forecast - By Deployment
    • 6.2.1. Cloud-Based
    • 6.2.2. On-Premise
    • 6.2.3. Hybrid
  • 6.3. Market Analysis, Insights and Forecast - By Technology
    • 6.3.1. Machine Learning & Deep Learning
    • 6.3.2. Computer Vision
    • 6.3.3. Others
  • 6.4. Market Analysis, Insights and Forecast - By Manufacturing Stage
    • 6.4.1. R&D/Tech Transfer
    • 6.4.2. Upstream Processing
    • 6.4.3. Downstream Processing
    • 6.4.4. Fill-Finish & Packaging
    • 6.4.5. Quality Control/QA
    • 6.4.6. Others
  • 6.5. Market Analysis, Insights and Forecast - By Application
    • 6.5.1. Production Planning & Scheduling
    • 6.5.2. Process Optimization & Control
    • 6.5.3. Quality Inspection & Assurance
    • 6.5.4. Predictive Maintenance
    • 6.5.5. Batch Record Review & Compliance
    • 6.5.6. Supply Chain & Inventory Optimization
    • 6.5.7. Others
  • 6.6. Market Analysis, Insights and Forecast - By Product
    • 6.6.1. Small Molecule Drugs
    • 6.6.2. Biologics
    • 6.6.3. Vaccines
    • 6.6.4. Cell & Gene Therapies
    • 6.6.5. Others
  • 6.7. Market Analysis, Insights and Forecast - By End User
    • 6.7.1. Pharmaceutical Companies
    • 6.7.2. Biotechnology Companies
    • 6.7.3. CDMOs/CMOs
    • 6.7.4. Cell & Gene Therapy Manufacturers
    • 6.7.5. Others
  • 6.8. Market Analysis, Insights and Forecast - By Country
    • 6.8.1. U.S.
    • 6.8.2. Canada

7. Europe AI in Pharma Manufacturing Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Component
    • 7.1.1. Software/Platforms
    • 7.1.2. Services
  • 7.2. Market Analysis, Insights and Forecast - By Deployment
    • 7.2.1. Cloud-Based
    • 7.2.2. On-Premise
    • 7.2.3. Hybrid
  • 7.3. Market Analysis, Insights and Forecast - By Technology
    • 7.3.1. Machine Learning & Deep Learning
    • 7.3.2. Computer Vision
    • 7.3.3. Others
  • 7.4. Market Analysis, Insights and Forecast - By Manufacturing Stage
    • 7.4.1. R&D/Tech Transfer
    • 7.4.2. Upstream Processing
    • 7.4.3. Downstream Processing
    • 7.4.4. Fill-Finish & Packaging
    • 7.4.5. Quality Control/QA
    • 7.4.6. Others
  • 7.5. Market Analysis, Insights and Forecast - By Application
    • 7.5.1. Production Planning & Scheduling
    • 7.5.2. Process Optimization & Control
    • 7.5.3. Quality Inspection & Assurance
    • 7.5.4. Predictive Maintenance
    • 7.5.5. Batch Record Review & Compliance
    • 7.5.6. Supply Chain & Inventory Optimization
    • 7.5.7. Others
  • 7.6. Market Analysis, Insights and Forecast - By Product
    • 7.6.1. Small Molecule Drugs
    • 7.6.2. Biologics
    • 7.6.3. Vaccines
    • 7.6.4. Cell & Gene Therapies
    • 7.6.5. Others
  • 7.7. Market Analysis, Insights and Forecast - By End User
    • 7.7.1. Pharmaceutical Companies
    • 7.7.2. Biotechnology Companies
    • 7.7.3. CDMOs/CMOs
    • 7.7.4. Cell & Gene Therapy Manufacturers
    • 7.7.5. Others
  • 7.8. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 7.8.1. U.K.
    • 7.8.2. Germany
    • 7.8.3. France
    • 7.8.4. Italy
    • 7.8.5. Spain
    • 7.8.6. Scandinavia
    • 7.8.7. Rest of Europe

8. Asia Pacific AI in Pharma Manufacturing Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Component
    • 8.1.1. Software/Platforms
    • 8.1.2. Services
  • 8.2. Market Analysis, Insights and Forecast - By Deployment
    • 8.2.1. Cloud-Based
    • 8.2.2. On-Premise
    • 8.2.3. Hybrid
  • 8.3. Market Analysis, Insights and Forecast - By Technology
    • 8.3.1. Machine Learning & Deep Learning
    • 8.3.2. Computer Vision
    • 8.3.3. Others
  • 8.4. Market Analysis, Insights and Forecast - By Manufacturing Stage
    • 8.4.1. R&D/Tech Transfer
    • 8.4.2. Upstream Processing
    • 8.4.3. Downstream Processing
    • 8.4.4. Fill-Finish & Packaging
    • 8.4.5. Quality Control/QA
    • 8.4.6. Others
  • 8.5. Market Analysis, Insights and Forecast - By Application
    • 8.5.1. Production Planning & Scheduling
    • 8.5.2. Process Optimization & Control
    • 8.5.3. Quality Inspection & Assurance
    • 8.5.4. Predictive Maintenance
    • 8.5.5. Batch Record Review & Compliance
    • 8.5.6. Supply Chain & Inventory Optimization
    • 8.5.7. Others
  • 8.6. Market Analysis, Insights and Forecast - By Product
    • 8.6.1. Small Molecule Drugs
    • 8.6.2. Biologics
    • 8.6.3. Vaccines
    • 8.6.4. Cell & Gene Therapies
    • 8.6.5. Others
  • 8.7. Market Analysis, Insights and Forecast - By End User
    • 8.7.1. Pharmaceutical Companies
    • 8.7.2. Biotechnology Companies
    • 8.7.3. CDMOs/CMOs
    • 8.7.4. Cell & Gene Therapy Manufacturers
    • 8.7.5. Others
  • 8.8. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 8.8.1. China
    • 8.8.2. Japan
    • 8.8.3. India
    • 8.8.4. Australia
    • 8.8.5. Southeast Asia
    • 8.8.6. Rest of Asia Pacific

9. Latin America AI in Pharma Manufacturing Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Component
    • 9.1.1. Software/Platforms
    • 9.1.2. Services
  • 9.2. Market Analysis, Insights and Forecast - By Deployment
    • 9.2.1. Cloud-Based
    • 9.2.2. On-Premise
    • 9.2.3. Hybrid
  • 9.3. Market Analysis, Insights and Forecast - By Technology
    • 9.3.1. Machine Learning & Deep Learning
    • 9.3.2. Computer Vision
    • 9.3.3. Others
  • 9.4. Market Analysis, Insights and Forecast - By Manufacturing Stage
    • 9.4.1. R&D/Tech Transfer
    • 9.4.2. Upstream Processing
    • 9.4.3. Downstream Processing
    • 9.4.4. Fill-Finish & Packaging
    • 9.4.5. Quality Control/QA
    • 9.4.6. Others
  • 9.5. Market Analysis, Insights and Forecast - By Application
    • 9.5.1. Production Planning & Scheduling
    • 9.5.2. Process Optimization & Control
    • 9.5.3. Quality Inspection & Assurance
    • 9.5.4. Predictive Maintenance
    • 9.5.5. Batch Record Review & Compliance
    • 9.5.6. Supply Chain & Inventory Optimization
    • 9.5.7. Others
  • 9.6. Market Analysis, Insights and Forecast - By Product
    • 9.6.1. Small Molecule Drugs
    • 9.6.2. Biologics
    • 9.6.3. Vaccines
    • 9.6.4. Cell & Gene Therapies
    • 9.6.5. Others
  • 9.7. Market Analysis, Insights and Forecast - By End User
    • 9.7.1. Pharmaceutical Companies
    • 9.7.2. Biotechnology Companies
    • 9.7.3. CDMOs/CMOs
    • 9.7.4. Cell & Gene Therapy Manufacturers
    • 9.7.5. Others
  • 9.8. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 9.8.1. Brazil
    • 9.8.2. Mexico
    • 9.8.3. Rest of Latin America

10. Middle East & Africa AI in Pharma Manufacturing Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Component
    • 10.1.1. Software/Platforms
    • 10.1.2. Services
  • 10.2. Market Analysis, Insights and Forecast - By Deployment
    • 10.2.1. Cloud-Based
    • 10.2.2. On-Premise
    • 10.2.3. Hybrid
  • 10.3. Market Analysis, Insights and Forecast - By Technology
    • 10.3.1. Machine Learning & Deep Learning
    • 10.3.2. Computer Vision
    • 10.3.3. Others
  • 10.4. Market Analysis, Insights and Forecast - By Manufacturing Stage
    • 10.4.1. R&D/Tech Transfer
    • 10.4.2. Upstream Processing
    • 10.4.3. Downstream Processing
    • 10.4.4. Fill-Finish & Packaging
    • 10.4.5. Quality Control/QA
    • 10.4.6. Others
  • 10.5. Market Analysis, Insights and Forecast - By Application
    • 10.5.1. Production Planning & Scheduling
    • 10.5.2. Process Optimization & Control
    • 10.5.3. Quality Inspection & Assurance
    • 10.5.4. Predictive Maintenance
    • 10.5.5. Batch Record Review & Compliance
    • 10.5.6. Supply Chain & Inventory Optimization
    • 10.5.7. Others
  • 10.6. Market Analysis, Insights and Forecast - By Product
    • 10.6.1. Small Molecule Drugs
    • 10.6.2. Biologics
    • 10.6.3. Vaccines
    • 10.6.4. Cell & Gene Therapies
    • 10.6.5. Others
  • 10.7. Market Analysis, Insights and Forecast - By End User
    • 10.7.1. Pharmaceutical Companies
    • 10.7.2. Biotechnology Companies
    • 10.7.3. CDMOs/CMOs
    • 10.7.4. Cell & Gene Therapy Manufacturers
    • 10.7.5. Others
  • 10.8. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 10.8.1. GCC
    • 10.8.2. South Africa
    • 10.8.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. Siemens AG
    • 11.2.2. Rockwell Automation, Inc.
    • 11.2.3. Honeywell International Inc.
    • 11.2.4. Emerson Electric Co.
    • 11.2.5. Schneider Electric
    • 11.2.6. ABB
    • 11.2.7. Korber AG.
    • 11.2.8. Dassault Systemes
    • 11.2.9. Danaher Corporation (Cytiva)
    • 11.2.10. MasterControl Solutions, Inc.
Show more
Product Code: FBI117654

List of Tables

  • Table 1: Global AI in Pharma Manufacturing Market Revenue (USD Billion) Forecast, By Component, 2021-2034
  • Table 2: Global AI in Pharma Manufacturing Market Revenue (USD Billion) Forecast, By Deployment, 2021-2034
  • Table 3: Global AI in Pharma Manufacturing Market Revenue (USD Billion) Forecast, By Technology, 2021-2034
  • Table 4: Global AI in Pharma Manufacturing Market Revenue (USD Billion) Forecast, By Manufacturing Stage, 2021-2034
  • Table 5: Global AI in Pharma Manufacturing Market Revenue (USD Billion) Forecast, By Application, 2021-2034
  • Table 6: Global AI in Pharma Manufacturing Market Revenue (USD Billion) Forecast, By Product, 2021-2034
  • Table 7: Global AI in Pharma Manufacturing Market Revenue (USD Billion) Forecast, By End User, 2021-2034
  • Table 8: Global AI in Pharma Manufacturing Market Revenue (USD Billion) Forecast, By Region, 2021-2034
  • Table 9: North America AI in Pharma Manufacturing Market Revenue (USD Billion) Forecast, By Component, 2021-2034
  • Table 10: North America AI in Pharma Manufacturing Market Revenue (USD Billion) Forecast, By Deployment, 2021-2034
  • Table 11: North America AI in Pharma Manufacturing Market Revenue (USD Billion) Forecast, By Technology, 2021-2034
  • Table 12: North America AI in Pharma Manufacturing Market Revenue (USD Billion) Forecast, By Manufacturing Stage, 2021-2034
  • Table 13: North America AI in Pharma Manufacturing Market Revenue (USD Billion) Forecast, By Application, 2021-2034
  • Table 14: North America AI in Pharma Manufacturing Market Revenue (USD Billion) Forecast, By Product, 2021-2034
  • Table 15: North America AI in Pharma Manufacturing Market Revenue (USD Billion) Forecast, By End User, 2021-2034
  • Table 16: North America AI in Pharma Manufacturing Market Revenue (USD Billion) Forecast, by Country, 2021-2034
  • Table 17: Europe AI in Pharma Manufacturing Market Revenue (USD Billion) Forecast, By Component, 2021-2034
  • Table 18: Europe AI in Pharma Manufacturing Market Revenue (USD Billion) Forecast, By Deployment, 2021-2034
  • Table 19: Europe AI in Pharma Manufacturing Market Revenue (USD Billion) Forecast, By Technology, 2021-2034
  • Table 20: Europe AI in Pharma Manufacturing Market Revenue (USD Billion) Forecast, By Manufacturing Stage, 2021-2034
  • Table 21: Europe AI in Pharma Manufacturing Market Revenue (USD Billion) Forecast, By Application, 2021-2034
  • Table 22: Europe AI in Pharma Manufacturing Market Revenue (USD Billion) Forecast, By Product, 2021-2034
  • Table 23: Europe AI in Pharma Manufacturing Market Revenue (USD Billion) Forecast, By End User, 2021-2034
  • Table 24: Europe AI in Pharma Manufacturing Market Revenue (USD Billion) Forecast, by Country/ Sub-region, 2021-2034
  • Table 25: Asia Pacific AI in Pharma Manufacturing Market Revenue (USD Billion) Forecast, By Component, 2021-2034
  • Table 26: Asia Pacific AI in Pharma Manufacturing Market Revenue (USD Billion) Forecast, By Deployment, 2021-2034
  • Table 27: Asia Pacific AI in Pharma Manufacturing Market Revenue (USD Billion) Forecast, By Technology, 2021-2034
  • Table 28: Asia Pacific AI in Pharma Manufacturing Market Revenue (USD Billion) Forecast, By Manufacturing Stage, 2021-2034
  • Table 29: Asia Pacific AI in Pharma Manufacturing Market Revenue (USD Billion) Forecast, By Application, 2021-2034
  • Table 30: Asia Pacific AI in Pharma Manufacturing Market Revenue (USD Billion) Forecast, By Product, 2021-2034
  • Table 31: Asia Pacific AI in Pharma Manufacturing Market Revenue (USD Billion) Forecast, By End User, 2021-2034
  • Table 32: Asia Pacific AI in Pharma Manufacturing Market Revenue (USD Billion) Forecast, by Country/ Sub-region, 2021-2034
  • Table 33: Latin America AI in Pharma Manufacturing Market Revenue (USD Billion) Forecast, By Component, 2021-2034
  • Table 34: Latin America AI in Pharma Manufacturing Market Revenue (USD Billion) Forecast, By Deployment, 2021-2034
  • Table 35: Latin America AI in Pharma Manufacturing Market Revenue (USD Billion) Forecast, By Technology, 2021-2034
  • Table 36: Latin America AI in Pharma Manufacturing Market Revenue (USD Billion) Forecast, By Manufacturing Stage, 2021-2034
  • Table 37: Latin America AI in Pharma Manufacturing Market Revenue (USD Billion) Forecast, By Application, 2021-2034
  • Table 38: Latin America AI in Pharma Manufacturing Market Revenue (USD Billion) Forecast, By Product, 2021-2034
  • Table 39: Latin America AI in Pharma Manufacturing Market Revenue (USD Billion) Forecast, By End User, 2021-2034
  • Table 40: Latin America AI in Pharma Manufacturing Market Revenue (USD Billion) Forecast, by Country/ Sub-region, 2021-2034
  • Table 41: Middle East & Africa AI in Pharma Manufacturing Market Revenue (USD Billion) Forecast, By Component, 2021-2034
  • Table 42: Middle East & Africa AI in Pharma Manufacturing Market Revenue (USD Billion) Forecast, By Deployment, 2021-2034
  • Table 43: Middle East & Africa AI in Pharma Manufacturing Market Revenue (USD Billion) Forecast, By Technology, 2021-2034
  • Table 44: Middle East & Africa AI in Pharma Manufacturing Market Revenue (USD Billion) Forecast, By Manufacturing Stage, 2021-2034
  • Table 45: Middle East & Africa AI in Pharma Manufacturing Market Revenue (USD Billion) Forecast, By Application, 2021-2034
  • Table 46: Middle East & Africa AI in Pharma Manufacturing Market Revenue (USD Billion) Forecast, By Product, 2021-2034
  • Table 47: Middle East & Africa AI in Pharma Manufacturing Market Revenue (USD Billion) Forecast, By End User, 2021-2034
  • Table 48: Middle East & Africa AI in Pharma Manufacturing Market Revenue (USD Billion) Forecast, by Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1: Global AI in Pharma Manufacturing Market Revenue Breakdown (USD Billion, %) By Region, 2025 & 2034
  • Figure 2: Global AI in Pharma Manufacturing Market Value Share (%), By Component, 2025 & 2034
  • Figure 3: Global AI in Pharma Manufacturing Market Value Share (%), By Deployment, 2025 & 2034
  • Figure 4: Global AI in Pharma Manufacturing Market Value Share (%), By Technology, 2025 & 2034
  • Figure 5: Global AI in Pharma Manufacturing Market Value Share (%), By Manufacturing Stage, 2025 & 2034
  • Figure 6: Global AI in Pharma Manufacturing Market Value Share (%), By Application, 2025 & 2034
  • Figure 7: Global AI in Pharma Manufacturing Market Value Share (%), By Product, 2025 & 2034
  • Figure 8: Global AI in Pharma Manufacturing Market Value Share (%), By End User, 2025 & 2034
  • Figure 9: Global AI in Pharma Manufacturing Market Value Share (%), By Region, 2025 & 2034
  • Figure 10: North America AI in Pharma Manufacturing Market Value (USD Billion), By Component, 2025 & 2034
  • Figure 11: North America AI in Pharma Manufacturing Market Value Share (%), By Component, 2025
  • Figure 12: North America AI in Pharma Manufacturing Market Value (USD Billion), By Deployment, 2025 & 2034
  • Figure 13: North America AI in Pharma Manufacturing Market Value Share (%), By Deployment, 2025
  • Figure 14: North America AI in Pharma Manufacturing Market Value (USD Billion), By Technology, 2025 & 2034
  • Figure 15: North America AI in Pharma Manufacturing Market Value Share (%), By Technology, 2025
  • Figure 16: North America AI in Pharma Manufacturing Market Value (USD Billion), By Manufacturing Stage, 2025 & 2034
  • Figure 17: North America AI in Pharma Manufacturing Market Value Share (%), By Manufacturing Stage, 2025
  • Figure 18: North America AI in Pharma Manufacturing Market Value (USD Billion), By Application, 2025 & 2034
  • Figure 19: North America AI in Pharma Manufacturing Market Value Share (%), By Application, 2025
  • Figure 20: North America AI in Pharma Manufacturing Market Value (USD Billion), By Product, 2025 & 2034
  • Figure 21: North America AI in Pharma Manufacturing Market Value Share (%), By Product, 2025
  • Figure 22: North America AI in Pharma Manufacturing Market Value (USD Billion), By End User, 2025 & 2034
  • Figure 23: North America AI in Pharma Manufacturing Market Value Share (%), By End User, 2025
  • Figure 24: North America AI in Pharma Manufacturing Market Value (USD Billion), by Country, 2025 & 2034
  • Figure 25: North America AI in Pharma Manufacturing Market Value Share (%), by Country, 2025
  • Figure 26: Europe AI in Pharma Manufacturing Market Value (USD Billion), By Component, 2025 & 2034
  • Figure 27: Europe AI in Pharma Manufacturing Market Value Share (%), By Component, 2025
  • Figure 28: Europe AI in Pharma Manufacturing Market Value (USD Billion), By Deployment, 2025 & 2034
  • Figure 29: Europe AI in Pharma Manufacturing Market Value Share (%), By Deployment, 2025
  • Figure 30: Europe AI in Pharma Manufacturing Market Value (USD Billion), By Technology, 2025 & 2034
  • Figure 31: Europe AI in Pharma Manufacturing Market Value Share (%), By Technology, 2025
  • Figure 32: Europe AI in Pharma Manufacturing Market Value (USD Billion), By Manufacturing Stage, 2025 & 2034
  • Figure 33: Europe AI in Pharma Manufacturing Market Value Share (%), By Manufacturing Stage, 2025
  • Figure 34: Europe AI in Pharma Manufacturing Market Value (USD Billion), By Application, 2025 & 2034
  • Figure 35: Europe AI in Pharma Manufacturing Market Value Share (%), By Application, 2025
  • Figure 36: Europe AI in Pharma Manufacturing Market Value (USD Billion), By Product, 2025 & 2034
  • Figure 37: Europe AI in Pharma Manufacturing Market Value Share (%), By Product, 2025
  • Figure 38: Europe AI in Pharma Manufacturing Market Value (USD Billion), By End User, 2025 & 2034
  • Figure 39: Europe AI in Pharma Manufacturing Market Value Share (%), By End User, 2025
  • Figure 40: Europe AI in Pharma Manufacturing Market Value (USD Billion), by Country/ Sub-region, 2025 & 2034
  • Figure 41: Europe AI in Pharma Manufacturing Market Value Share (%), by Country/ Sub-region, 2025
  • Figure 42: Asia Pacific AI in Pharma Manufacturing Market Value (USD Billion), By Component, 2025 & 2034
  • Figure 43: Asia Pacific AI in Pharma Manufacturing Market Value Share (%), By Component, 2025
  • Figure 44: Asia Pacific AI in Pharma Manufacturing Market Value (USD Billion), By Deployment, 2025 & 2034
  • Figure 45: Asia Pacific AI in Pharma Manufacturing Market Value Share (%), By Deployment, 2025
  • Figure 46: Asia Pacific AI in Pharma Manufacturing Market Value (USD Billion), By Technology, 2025 & 2034
  • Figure 47: Asia Pacific AI in Pharma Manufacturing Market Value Share (%), By Technology, 2025
  • Figure 48: Asia Pacific AI in Pharma Manufacturing Market Value (USD Billion), By Manufacturing Stage, 2025 & 2034
  • Figure 49: Asia Pacific AI in Pharma Manufacturing Market Value Share (%), By Manufacturing Stage, 2025
  • Figure 50: Asia Pacific AI in Pharma Manufacturing Market Value (USD Billion), By Application, 2025 & 2034
  • Figure 51: Asia Pacific AI in Pharma Manufacturing Market Value Share (%), By Application, 2025
  • Figure 52: Asia Pacific AI in Pharma Manufacturing Market Value (USD Billion), By Product, 2025 & 2034
  • Figure 53: Asia Pacific AI in Pharma Manufacturing Market Value Share (%), By Product, 2025
  • Figure 54: Asia Pacific AI in Pharma Manufacturing Market Value (USD Billion), By End User, 2025 & 2034
  • Figure 55: Asia Pacific AI in Pharma Manufacturing Market Value Share (%), By End User, 2025
  • Figure 56: Asia Pacific AI in Pharma Manufacturing Market Value (USD Billion), by Country/ Sub-region, 2025 & 2034
  • Figure 57: Asia Pacific AI in Pharma Manufacturing Market Value Share (%), by Country/ Sub-region, 2025
  • Figure 58: Latin America AI in Pharma Manufacturing Market Value (USD Billion), By Component, 2025 & 2034
  • Figure 59: Latin America AI in Pharma Manufacturing Market Value Share (%), By Component, 2025
  • Figure 60: Latin America AI in Pharma Manufacturing Market Value (USD Billion), By Deployment, 2025 & 2034
  • Figure 61: Latin America AI in Pharma Manufacturing Market Value Share (%), By Deployment, 2025
  • Figure 62: Latin America AI in Pharma Manufacturing Market Value (USD Billion), By Technology, 2025 & 2034
  • Figure 63: Latin America AI in Pharma Manufacturing Market Value Share (%), By Technology, 2025
  • Figure 64: Latin America AI in Pharma Manufacturing Market Value (USD Billion), By Manufacturing Stage, 2025 & 2034
  • Figure 65: Latin America AI in Pharma Manufacturing Market Value Share (%), By Manufacturing Stage, 2025
  • Figure 66: Latin America AI in Pharma Manufacturing Market Value (USD Billion), By Application, 2025 & 2034
  • Figure 67: Latin America AI in Pharma Manufacturing Market Value Share (%), By Application, 2025
  • Figure 68: Latin America AI in Pharma Manufacturing Market Value (USD Billion), By Product, 2025 & 2034
  • Figure 69: Latin America AI in Pharma Manufacturing Market Value Share (%), By Product, 2025
  • Figure 70: Latin America AI in Pharma Manufacturing Market Value (USD Billion), By End User, 2025 & 2034
  • Figure 71: Latin America AI in Pharma Manufacturing Market Value Share (%), By End User, 2025
  • Figure 72: Latin America AI in Pharma Manufacturing Market Value (USD Billion), by Country/ Sub-region, 2025 & 2034
  • Figure 73: Latin America AI in Pharma Manufacturing Market Value Share (%), by Country/ Sub-region, 2025
  • Figure 74: Middle East & Africa AI in Pharma Manufacturing Market Value (USD Billion), By Component, 2025 & 2034
  • Figure 75: Middle East & Africa AI in Pharma Manufacturing Market Value Share (%), By Component, 2025
  • Figure 76: Middle East & Africa AI in Pharma Manufacturing Market Value (USD Billion), By Deployment, 2025 & 2034
  • Figure 77: Middle East & Africa AI in Pharma Manufacturing Market Value Share (%), By Deployment, 2025
  • Figure 78: Middle East & Africa AI in Pharma Manufacturing Market Value (USD Billion), By Technology, 2025 & 2034
  • Figure 79: Middle East & Africa AI in Pharma Manufacturing Market Value Share (%), By Technology, 2025
  • Figure 80: Middle East & Africa AI in Pharma Manufacturing Market Value (USD Billion), By Manufacturing Stage, 2025 & 2034
  • Figure 81: Middle East & Africa AI in Pharma Manufacturing Market Value Share (%), By Manufacturing Stage, 2025
  • Figure 82: Middle East & Africa AI in Pharma Manufacturing Market Value (USD Billion), By Application, 2025 & 2034
  • Figure 83: Middle East & Africa AI in Pharma Manufacturing Market Value Share (%), By Application, 2025
  • Figure 84: Middle East & Africa AI in Pharma Manufacturing Market Value (USD Billion), By Product, 2025 & 2034
  • Figure 85: Middle East & Africa AI in Pharma Manufacturing Market Value Share (%), By Product, 2025
  • Figure 86: Middle East & Africa AI in Pharma Manufacturing Market Value (USD Billion), By End User, 2025 & 2034
  • Figure 87: Middle East & Africa AI in Pharma Manufacturing Market Value Share (%), By End User, 2025
  • Figure 88: Middle East & Africa AI in Pharma Manufacturing Market Value (USD Billion), by Country/ Sub-region, 2025 & 2034
  • Figure 89: Middle East & Africa AI in Pharma Manufacturing Market Value Share (%), by Country/ Sub-region, 2025
  • Figure 90: Global AI in Pharma Manufacturing Market Share (%), by Company, 2025
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!